PURPOSE: The aim of this study was to evaluate the contribution of an injection of hyaluronic acid (HA) between the rectum and the prostate for reducing the dose to the rectal wall in a hypofractionated irradiation for prostate cancer.
METHODS AND MATERIALS: In a phase 2 study, 10 cc of HA was injected between the rectum and prostate. For 16 patients, the same intensity modulated radiation therapy plan (62 Gy in 20 fractions) was optimized on 2 computed tomography scans: CT1 (before injection) and CT2 (after injection). Rectal parameters were compared: dose to 2.5 cc (D2.5), 5 cc (D5), 10 cc (D10), 15 cc (D15), and 20 cc (D20) of rectal wall and volume of rectum covered by the 90% isodose line (V90), 80% (V80), 70% (V70), 60% (V60), and 50% (V50).
RESULTS: The mean V90, V80, V70, V60, and V50 values were reduced by 73.8% (P<.0001), 55.7% (P=.0003), 43.0% (P=.007), 34% (P=.002), and 25% (P=.036), respectively. The average values of D2.5, D5, D10, D15, and D20 were reduced by 8.5 Gy (P<.0001), 12.3 Gy (P< .0001), 8.4 Gy (P=.005), 3.7 Gy (P=.026), and 1.2 Gy (P=.25), respectively.
CONCLUSIONS: The injection of HA significantly limited radiation doses to the rectal wall.
Written by:
Chapet O, Udrescu C, Devonec M, Tanguy R, Sotton MP, Enachescu C, Colombel M, Azria D, Jalade P, Ruffion A. Are you the author?
Department of Radiation Oncology, Centre Hospitalier Lyon Sud, Pierre Benite, France.
Reference: Int J Radiat Oncol Biol Phys. 2013 Jan 3. pii: S0360-3016(12)03825-4.
doi: 10.1016/j.ijrobp.2012.11.027
PubMed Abstract
PMID: 23290444
UroToday.com Prostate Cancer Section
